ANTIGENS

ANTIGENS

Infectious diseases caused by viruses, bacteria, fungi, and parasites continue to pose serious health threats worldwide.

Major outbreaks like SARS-CoV-2 and historical pandemics have shown the devastating impact of such infections.

To combat these threats, the scientific and medical communities are focused on developing effective vaccines and therapeutics, supported by companies like ACRO Biosystems with advanced reagent platforms.

Allianz Bio provides high-quality viral antigens and core reagents to support vaccine and drug development for infectious diseases.

This product line helps accelerate research, clinical trials, and diagnostic development with reliable, high-performance materials.​

Example Image

RSV Influenza VZV MPXV HIV RABV HSV NiV HeV ZIKV
DENV SFTSV EBV EBOV Rotavirus Coxsackievirus LCMV Vaccinia Virus HCMV hMPV
JEV HPV MuV HTNV TBEV SARS-CoV-2

Main Features
  • HEK293 expression: the protein structure is closer to the natural conformation;
  • High purity verified by SDS-PAGE and MALS;
  • High Bioactivity verified by antigen-antibody or antigen-receptor binding experiments;
  • High immunogenicity, which can induce higher antibody titers;
  • It can be used for drug screening and vaccine development.
Example Image
Partner Logo